Response to comments by Seaman et al. on "Analysis of longitudinal trials with protocol deviation: a framework for relevant, accessible assumptions, and inference via multiple imputation," Journal of Biopharmaceutical Statistics 23:1352-1371

J Biopharm Stat. 2014;24(6):1363-9. doi: 10.1080/10543406.2014.960085.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Data Interpretation, Statistical*
  • Humans
  • Models, Statistical*
  • Randomized Controlled Trials as Topic / statistics & numerical data*